Sign in
4/A

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000026

Chief Operating Officer acquired 14,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dowden Nathan J · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-01 Grant or award : show line 1 in the form +14,200 58,455 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +21,500 21,500 D
Loading xslF345X04/wf-form4a_168194078070459.xml…